Use of Tamoxifen and Raloxifene for Breast Cancer Chemoprevention in 2010

PURPOSE: Two selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene, have been shown in randomized clinical trials to reduce the risk of developing primary invasive breast cancer (IBC) in high-risk women. In 1998, the U.S. Food and Drug Administration (FDA) used these studies as a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Waters, Erika A., McNeel, Timothy S., McCaskill Stevens, Worta, Freedman, Andrew N.
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3771085/
https://ncbi.nlm.nih.gov/pubmed/22622807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2089-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker